1. Elevation in body temperature may increase susceptibility to cortical spreading depression in a rat model.
- Author
-
Kitamura E, Kanazawa N, Iizuka T, and Nishiyama K
- Subjects
- Animals, Male, Rats, Cerebrovascular Circulation physiology, Rats, Sprague-Dawley, Cortical Spreading Depression physiology, Body Temperature physiology, Disease Models, Animal
- Abstract
One characteristic of migraine is recurrent headache attacks, which are known to be induced by changes in climatic variables such as atmospheric pressure, humidity, and outside temperature. However, the relationship between temperature changes and migraine remains unclear. Therefore, we investigated the relationship between body temperature changes and cortical spreading depression (CSD) using KCl-induced rat models of CSD. We initially induced CSD under controlled conditions at a room temperature of 28°C on an operating table maintained at 37°C. Subsequently, we controlled the operating table temperature to induce a second round of CSD under conditions of either a 10 ± 1% increase or decrease in body temperature. We ensured 1 h rest period between the first and second inductions of CSD. The results indicated that the number of CSDs significantly increased after body temperature elevation (before, 8.8 ± 1.2 times vs. after, 13.4 ± 1.3 times; p = 0.0003). The mean percentage change in cerebral blood flow decreased after body temperature increased (before, 33.1 ± 2.4% vs. after, 18.2 ± 1.4%; p = 0.006). There were no significant changes in CSD after body temperature decreased. The susceptibility of the cortex to CSD may increase under conditions of elevated body temperature., Competing Interests: Conflict of Interest K. N. received research support from Daiichi Sankyo Co., Ltd., Dainippon Sumitomo Pharma Co., Ltd., and Eisai Co., Ltd. T.I. received research support from Astellas Pharma Inc. The other authors have nothing to disclose regarding conflicts of interest or commercial relationships, including grants, honoraria, speaker lists, significant ownership, or financial support from pharmaceutical or other companies., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF